Hippocampal dysfunction defines disease onset in Huntington's disease

被引:45
|
作者
Begeti, Faye [1 ]
Schwab, Laetitia C. [1 ]
Mason, Sarah L. [1 ]
Barker, Roger A. [1 ,2 ]
机构
[1] Univ Cambridge, Dept Clin Neurosci, John van Geest Ctr Brain Repair, Forvie Site,Robinson Way, Cambridge CB2 0PY, England
[2] Addenbrookes Hosp, Dept Neurol, Cambridge, England
来源
关键词
TRANSGENIC MOUSE MODEL; SYNAPTIC PLASTICITY; RECOGNITION MEMORY; NEUROGENESIS; NAVIGATION; IMPAIRMENTS; RECEPTORS; COGNITION; DEMENTIA; DEFICITS;
D O I
10.1136/jnnp-2015-312413
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder characterised by a triad of motor, psychiatric and cognitive deficits with the latter classically attributed to disruption of frontostriatal networks. However, emerging evidence from animal models of HD suggests that some of the early cognitive deficits may have a hippocampal basis. The objective of this study was to link previous rodent findings in this area to clinical practice. Methods In this study, 94 participants included patients with early HD, premanifest HD and age-matched controls underwent hippocampal-based cognitive assessments. These included a virtual reality version of the Morris water maze, a task involved participants having to swim through a virtual pool to find a submerged platform using a joystick, and the Cambridge Neuropsychological Test Automated Battery (CANTAB) paired associates learning task, a test also known to rely on hippocampal integrity. Results Patients with early HD showed impaired performance in both the virtual Morris water maze and the CANTAB paired associates learning. Such deficits were also correlated with estimated years to diagnosis in premanifest participants. Conclusions This study highlights the merit of using analogous tests in the laboratory and clinic and demonstrates that hippocampal impairments are an early feature of HD in patients as previously shown in rodent models of the disease. As such, they could be used not only to assist in the diagnosis of disease onset, but may also be useful as an outcome measure in future therapeutic trials.
引用
收藏
页码:975 / 981
页数:7
相关论文
共 50 条
  • [21] Progress in Huntington's disease: the search for markers of disease onset and progression
    Mason, Sarah
    Barker, Roger A.
    JOURNAL OF NEUROLOGY, 2015, 262 (08) : 1990 - 1995
  • [22] Progress in Huntington’s disease: the search for markers of disease onset and progression
    Sarah Mason
    Roger A. Barker
    Journal of Neurology, 2015, 262 : 1990 - 1995
  • [23] Longitudinal Metabolite Changes in Huntington's Disease During Disease Onset
    van den Bogaard, Simon J. A.
    Dumas, Eve M.
    Teeuwisse, Wouter M.
    Kan, Hermien E.
    Webb, Andrew
    van Buchem, Mark A.
    Roos, Raymund A. C.
    van der Grond, Jeroen
    JOURNAL OF HUNTINGTONS DISEASE, 2014, 3 (04) : 377 - 386
  • [24] Detecting Disease Onset in Huntington's Disease with a Simple Balance Assessment
    Mustafa, Andrea
    Corey-Bloom, Jody
    Gilbert, Paul E.
    Howell, Stephen
    Snell, Chase
    Castleton, Jordan
    Smith, Haileigh
    Goble, Daniel
    NEUROLOGY, 2021, 96 (15)
  • [25] Late onset vascular dysfunction in the R6/1 model of Huntington's disease
    Rahman, Awahan
    Ekman, Mari
    Shakirova, Yulia
    Andersson, Kristina E.
    Morgelin, Matthias
    Erjefalt, Jonas S.
    Brundin, Patrik
    Li, Jia-Yi
    Sward, Karl
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 698 (1-3) : 345 - 353
  • [26] Late onset vascular dysfunction in the R6/1 model of Huntington's disease
    Awahan, Reheman
    Mari, E.
    Yulia, S.
    Kristina, A.
    Matthias, M.
    Jonas, E.
    Patrik, B.
    Yili, J.
    Karl, S.
    ACTA PHYSIOLOGICA, 2015, 215 : 79 - 80
  • [27] Special Issue: Juvenile Onset Huntington's Disease
    Nopoulos, Peg C.
    BRAIN SCIENCES, 2020, 10 (09)
  • [28] INFLUENCE OF AGE OF ONSET ON HUNTINGTON'S DISEASE PHENOTYPE
    Larson, D.
    Kwa, L.
    Bega, D.
    Yeh, C.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E108 - E108
  • [29] Caffeine is a modifier of age at onset in Huntington's disease
    Duru, C.
    Simonin, C.
    Richard, F.
    Hincker, P.
    Salleron, J.
    Charles, P.
    Youssov, K.
    Burnouf, S.
    Azulay, J. -P.
    Verny, C.
    Tranchant, C.
    Goizet, C.
    Defebvre, L.
    Sablonniere, B.
    Romon, M.
    Buee, L.
    Amouyel, P.
    Godefroy, O.
    Durr, A.
    Bachoud-Levi, A. -C.
    Blum, D.
    Krystkowiak, P.
    MOVEMENT DISORDERS, 2011, 26 : S60 - S61
  • [30] Unusual early-onset Huntington's disease
    Vargas, AP
    Carod-Artal, FJ
    Bomfim, D
    Vázquez-Cabrera, C
    Dantas-Barbosa, C
    JOURNAL OF CHILD NEUROLOGY, 2003, 18 (06) : 429 - 432